Lineage Cell Therapeutics, Inc. (LCTX): Price and Financial Metrics
LCTX Price/Volume Stats
| Current price | $0.66 | 52-week high | $1.15 |
| Prev. close | $0.66 | 52-week low | $0.37 |
| Day low | $0.65 | Volume | 844,000 |
| Day high | $0.67 | Avg. volume | 1,500,781 |
| 50-day MA | $0.50 | Dividend yield | N/A |
| 200-day MA | $0.66 | Market Cap | 150.03M |
LCTX Stock Price Chart Interactive Chart >
Lineage Cell Therapeutics, Inc. (LCTX) Company Bio
Lineage Cell Therapeutics, Inc. operates as a biotechnology company. The Company offers cell-based therapies and gene marker-based molecular diagnostics for diseases and degenerative conditions. Lineage Cell Therapeutics serves patients in the United States.
LCTX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
LCTX Price Returns
| 1-mo | 48.65% |
| 3-mo | 25.64% |
| 6-mo | 12.67% |
| 1-year | -32.65% |
| 3-year | -56.00% |
| 5-year | -25.84% |
| YTD | 31.34% |
| 2024 | -53.90% |
| 2023 | -6.84% |
| 2022 | -52.24% |
| 2021 | 39.20% |
| 2020 | 97.75% |